ActiGraft®
ActiGraft
Recreating the Natural Wound Healing Environment
ActiGraft, based on RedDress’ proprietary patented technology, is a FDA-cleared regenerative wound care solution that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering, biologic scaffold and wound microenvironment to promote the natural wound healing processes of the body.
Faster Application
Can be easily prepared at the patient’s bedside in 10 minutes
Cost Effective Treatment
Provides significant savings in nursing costs and simplifies wound treatment
Patient Comfort
Significantly faster healing with less wound interaction and patient pain
Easy Integration
Seamlessly integrates into current chronic wound treatment practices
Simplified Process
Enables front line staff to easily execute ongoing wound treatment
Natural Healing
Uses the patient’s own blood to promote the body’s natural healing processes
Take the Guessing Out of Wound Management
Standard of Care topical dressings address one or two aspects of a chronic wound bed. The ActiGraft dressing contains the provisional extracellular matrix acting not only as a scaffold, but as a signaling, binding and activating substrate that regulates the crosstalk between fibroblasts, keratinocytes, endothelial cells and key inflammatory cells - the big players in wound healing.
ActiGraft changes the way we treat chronic wounds by managing every stage of the wound healing process and taking the guesswork out of wound treatment.
ActiGraft Kit Procedure
Efficient Wound Treatment
- Provides the wound with an optimal, natural healing environment, allowing the healing process to proceed unhindered.
- Weekly vs. daily application saves facility staff nursing time.
- Published results of 72% complete healing within 12 weeks.
Simplified Procedures
- Single-use, state-of-the-art, autologous graft wound care solution.
- Designed with nurses in mind, ActiGraft can be easily prepared at the patient's bedside in 12 minutes.
- Ready to use right out of the box. Eliminates need for complex processing, temperature monitoring or storage.
Reduced Costs
- Because ActiGraft uses the patient’s own blood, we aren’t required to register as a tissue donor bank or go through the regulatory recording processes of skin substitutes. This reduces administration and documentation requirements.
- No capital equipment requirements.
- Reduced costs compared to other chronic wound treatments.
Increased Patient Safety and Comfort
- Created from the patient's blood, assuring safe and effective management of the wound.
- Significantly faster healing with less wound interaction and patient pain.
- Patients have reported reduced pain and improved quality of life. Unlike some other dressings, ActiGraft doesn’t abrade or irritate the skin’s dermal layer.
ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to:
- Diabetic/Neuropathic ulcers
- Pressure Ulcers/Injury
- Venous Stasis Ulcers
- Post-surgical wounds
- Traumatic wounds
- Skin Tears
- Radius of ActiGraft clot – 3cm (Diameter 6sq cm)
- Clot size: 28.3sq cm
- 18ml of blood required
- Storage conditions - Store in the original container at a room temperature of 5°C (41°F) – 30°C (86°F). Protect from freezing and avoid excessive heat.
Interested in Introducing ActiGraft
into your Practice?
ActiGraft® Virtual Training is a quick and easy program designed to fit your busy schedule. Begin treating patients immediately within your health care setting.
